Literature DB >> 9829768

The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study.

S Burnett1, B Hurwitz, C Davey, J Ray, N Chaturvedi, J Salzmann, J S Yudkin.   

Abstract

Diabetic retinopathy remains the most common cause of blindness in people of working age but the provision of high quality eye screening for diabetic patients is still erratic in many health districts in the UK. National consensus guidelines recommend comprehensive population coverage, high sensitivity (>80%), high specificity (>95%), agreed clinical criteria, referral procedures and centralized data collection to facilitate audit. This study looks at the effectiveness of implementing a prompted recall programme for retinal screening in an inner-city district of North London. The scheme uses trained, accredited optometrists to screen patients with diabetes who are looked after in the community by their general practitioner. During the first 17 months of the scheme, 63 optometrists attended training and gained accreditation. Of the 666 patients recruited, 645 were scheduled for screening and 536 (83%) attended. Fourteen per cent of patients screened were found to have background retinopathy and 2.3% sight-threatening eye disease. In two audits, carried out 15 months apart in a random sample of GP practices, the incidence of recorded dilated fundoscopy increased from 48% at baseline to 56%, an increase of 8% (95% CIs 2%-14%). For referable eye disease, the sensitivity of this screening technique was 100%, the specificity 94% (95% CIs 90%-98%), the positive predictive value 79% (95% CIs 72%-86%) and the negative predictive value 100%. The administrative cost per case screened was Pound Sterling 12.60 (excluding clinical costs and any additional optometry payment).

Entities:  

Mesh:

Year:  1998        PMID: 9829768     DOI: 10.1002/(sici)1096-9136(1998110)15:3+<s38::aid-dia729>3.3.co;2-k

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Complications of diabetes: screening for retinopathy and management of foot ulcers.

Authors:  A Melville; R Richardson; A McIntosh; C O'Keeffe; J Mason; J Peters; A Hutchinson
Journal:  Qual Health Care       Date:  2000-06

2.  Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.

Authors:  R L Thomas; F Dunstan; S D Luzio; S Roy Chowdury; S L Hale; R V North; R L Gibbins; D R Owens
Journal:  BMJ       Date:  2012-02-22

Review 3.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

4.  Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial.

Authors:  Fiona Riordan; Emmy Racine; Susan M Smith; Aileen Murphy; John Browne; Patricia M Kearney; Colin Bradley; Mark James; Mark Murphy; Sheena M McHugh
Journal:  Pilot Feasibility Stud       Date:  2020-05-12

5.  Development of an intervention to facilitate implementation and uptake of diabetic retinopathy screening.

Authors:  Fiona Riordan; Emmy Racine; Eunice T Phillip; Colin Bradley; Fabiana Lorencatto; Mark Murphy; Aileen Murphy; John Browne; Susan M Smith; Patricia M Kearney; Sheena M McHugh
Journal:  Implement Sci       Date:  2020-05-19       Impact factor: 7.327

6.  A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis.

Authors:  Fangyao Tang; Xi Wang; An-Ran Ran; Carmen K M Chan; Mary Ho; Wilson Yip; Alvin L Young; Jerry Lok; Simon Szeto; Jason Chan; Fanny Yip; Raymond Wong; Ziqi Tang; Dawei Yang; Danny S Ng; Li Jia Chen; Marten Brelén; Victor Chu; Kenneth Li; Tracy H T Lai; Gavin S Tan; Daniel S W Ting; Haifan Huang; Haoyu Chen; Jacey Hongjie Ma; Shibo Tang; Theodore Leng; Schahrouz Kakavand; Suria S Mannil; Robert T Chang; Gerald Liew; Bamini Gopinath; Timothy Y Y Lai; Chi Pui Pang; Peter H Scanlon; Tien Yin Wong; Clement C Tham; Hao Chen; Pheng-Ann Heng; Carol Y Cheung
Journal:  Diabetes Care       Date:  2021-07-27       Impact factor: 17.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.